Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.49 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.49 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | ELANE | P08246 | 3/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SCN4A | P35499 | 1/20 | 0.42 |
| ▸ | CTSC | P53634 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23356900 | 1.00 | DPP4 (0.49) | DPP4DPP8ANPEPELANEHTR2C | |
| SCHEMBL4447785 | 1.00 | DPP4 (0.49) | DPP4DPP8ANPEPELANEHTR2C | |
| Hydrochloric Acid SCHEMBL10521985 | 0.98 | DPP4 (0.50) | DPP4DPP8ANPEPELANEHTR2C | |
| SCHEMBL15155167 | 0.88 | ELANE (0.46) | DPP4DPP8ANPEPELANEHTR2C | |
| SCHEMBL28789042 | 0.84 | HTT (0.46) | HTR2CSMN1; SMN2HTTKMT2ATDP1 | |
| SCHEMBL29035303 | 0.84 | HTT (0.46) | DPP4HTR2CHTR2BSMN1; SMN2HTT | |
| SCHEMBL3060268 | 0.84 | HTT (0.46) | DPP4DPP8ELANEHTR2CHTR2B | |
| SCHEMBL16197773 | 0.84 | HTT (0.46) | DPP4DPP8ELANEHTR2CHTR2B | |
| SCHEMBL18295372 | 0.84 | HTT (0.46) | DPP4HTR2CHTR2BSMN1; SMN2HTT | |
| SCHEMBL27740311 | 0.84 | TDP1 (0.46) | DPP4DPP8ANPEPELANEHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | UNIV CALIFORNIA (US) | 2026-03-26 | — | — | US | disclosed |
| US-12485182-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-02 | — | — | US | disclosed |
| US-20230346960-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230286973-A1 | PROTEIN SECRETION INHIBITORS | ENODIA THERAPEUTICS SAS (FR) | 2023-09-14 | — | — | US | disclosed |
| US-11612663-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-28 | — | — | US | disclosed |
| US-20220313867-A1 | ENGINEERED SCAFFOLDS FOR VASCULARIZED TISSUE REPAIR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-10-06 | — | — | US | disclosed |
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | ENODIA THERAPEUTICS SAS (FR) | 2022-05-19 | — | — | US | disclosed |
| US-11246961-B2 | Engineered scaffolds for vascularized tissue repair | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-02-15 | — | — | US | disclosed |
| EP-3426700-B1 | ENGINEERED SCAFFOLDS FOR VASCULARIZED TISSUE REPAIR | UNIV CALIFORNIA (US) | 2021-12-15 | — | — | EP | disclosed |
| CN-110498808-B | Intermediate for synthesizing (2S,3R) -3-substituted phenyl pyrrolidine-2-carboxylic acid and preparation method and application thereof | 浙江晖石药业有限公司 | 2021-11-05 | — | — | CN | disclosed |
| US-9073974-B2 | RGD-containing cyclic peptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-07-07 | — | — | US | disclosed |
| US-20150165026-A1 | SINGLET OXYGEN-LABILE LINKERS AND METHODS OF PRODUCTION AND USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2015-06-18 | — | — | US | disclosed |
| US-20150165026-A1 | SINGLET OXYGEN-LABILE LINKERS AND METHODS OF PRODUCTION AND USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2015-06-18 | — | — | US | disclosed |
| WO-2013163321-A1 | SINGLET OXYGEN-LABILE LINKERS AND METHODS OF PRODUCTION AND USE THEREOF | YOU YOUNGJAE (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130172270-A1 | RGD-CONTAINING CYCLIC PEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-07-04 | — | — | US | disclosed |
| US-20130129972-A1 | Porous Thin Films | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-05-23 | — | — | US | disclosed |
| WO-2011079015-A1 | RGD-CONTAINING CYCLIC PEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-06-30 | — | — | WO | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346960-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, PDGFRB, TEK | DPP4 1591/4885DPP8 1261/4885ANPEP 960/4885 |
| US-20220313867-A1 | ENGINEERED SCAFFOLDS FOR VASCULARIZED TISSUE REPAIR | FLT4, FLT1, KDR | DPP4 1022/4885DPP8 1831/4885ANPEP 194/4885 |
| US-12485182-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | PDGFA, PDGFRB, TEK | DPP4 1591/4885DPP8 1261/4885ANPEP 960/4885 |
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | SEC61B, SEC61A1, SEC61G | DPP4 2157/4885DPP8 1605/4885ANPEP 719/4885 |
| US-20230286973-A1 | PROTEIN SECRETION INHIBITORS | SEC61B, SEC61A1, SEC61G | DPP4 2343/4885DPP8 1769/4885ANPEP 604/4885 |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, DCLRE1A, PDGFRA | DPP4 2242/4885DPP8 1566/4885ANPEP 380/4885 |
| US-11246961-B2 | Engineered scaffolds for vascularized tissue repair | FLT4, FLT1, KDR | DPP4 1022/4885DPP8 1831/4885ANPEP 194/4885 |
| US-11612663-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | PDGFA, PDGFRB, TEK | DPP4 1591/4885DPP8 1261/4885ANPEP 960/4885 |
| US-20150165026-A1 | SINGLET OXYGEN-LABILE LINKERS AND METHODS OF PRODUCTION AND USE THEREOF | PPOX, DUOX1, PAICS | DPP4 4430/4885DPP8 3786/4885ANPEP 1862/4885 |
| US-20130172270-A1 | RGD-CONTAINING CYCLIC PEPTIDES | ITGAV, ITGB3, ITGAL | DPP4 1930/4885DPP8 3002/4885ANPEP 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.